XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Other Intangible Assets
6 Months Ended
Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure [Text Block] OTHER INTANGIBLE ASSETS
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 
(In millions)June 30, 2021December 31, 2020June 30, 2020
 GrossAccumulated
Amortization
NetGrossAccumulated
Amortization
NetGrossAccumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived):
      
Germplasm$6,265 $(444)$5,821 $6,265 $(317)$5,948 $6,265 $(190)$6,075 
Customer-related
1,966 (434)1,532 1,984 (380)1,604 1,961 (322)1,639 
Developed technology
1,485 (603)882 1,451 (525)926 1,463 (462)1,001 
Trademarks/trade names1
2,013 (132)1,881 2,019 (99)1,920 161 (85)76 
Favorable supply contracts
475 (349)126 475 (302)173 475 (255)220 
Other2
404 (243)161 405 (239)166 405 (227)178 
Total other intangible assets with finite lives
12,608 (2,205)10,403 12,599 (1,862)10,737 10,730 (1,541)9,189 
Intangible assets not subject to amortization (Indefinite-lived):
      
IPR&D10 — 10 10 — 10 10 — 10 
Trade name1
1,871 — 1,871 
Total other intangible assets10 — 10 10 — 10 1,881 — 1,881 
Total$12,618 $(2,205)$10,413 $12,609 $(1,862)$10,747 $12,611 $(1,541)$11,070 
1.Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for the impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired.
2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $180 million and $363 million for the three and six months ended June 30, 2021, respectively, and $176 million and $339 million for the three and six months ended June 30, 2020, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2021 and each of the next five years is approximately $358 million, $701 million, $621 million, $607 million, $570 million and $559 million, respectively.